Brief: Polyrizon Submits Pre-Request For Designation To FDA For Pl-16 Viral Blocker
Brief: Polyrizon Completes FDA Pre-Submission Meeting For PL-14 Allergy Blocker Nasal Spray
Brief: Polyrizon Reports Positive Mucoadhesion Results For Intranasal Naloxone Hydrogel
NASDAQ RESUMED AT 01:38 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:33 PM
NASDAQ RESUMED AT 12:47 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:42 PM
NASDAQ RESUMED AT 12:27 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:22 PM
NASDAQ RESUMED AT 10:09 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:04 AM
NASDAQ RESUMED AT 09:53 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Polyrizon Files For Mixed Shelf Of Upto $50 Million - SEC Filing
Brief: Polyrizon Announces Positive In-Vitro Results For PL-16 Viral Blocker